Figure 1From: The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over studyExogenous glucagon-like peptide-1 (GLP-1) attenuated the rise in blood glucose levels and the overall glycaemic response to intra-duodenal nutrient infusion. (AUC30–270 min GLP-1 2077 ± 144 mmol/l min vs. placebo 2568 ± 208 mmol/l min; P = 0.02). Data are mean ± SEM (n = 7). * P < 0.05.Back to article page